Table 2.
Phospholipids | Triacylglycerols | Free fatty acids | ||||
---|---|---|---|---|---|---|
Pro | Ama | Pro | Ama | Pro | Ama | |
14:0 | 0.6 ± 0.3 | 3.0 ± 0.5** | 2.6 ± 0.8 | 4.0 ± 1.5 | 1.9 ± 0.7 | 4.0 ± 1.5 |
16:0 | 23.5 ± 3.2 | 26.5 ± 4.4 | 3.9 ± 0.9 | 10.5 ± 1.0** | 6.9 ± 0.6 | 23.3 ± 0.9** |
18:0 | 10.0 ± 1.7 | 9.7 ± 1.3 | 10.6 ± 1.2 | 10.0 ± 2.2 | 13.4 ± 1.9 | 13.0 ± 2.5 |
Total saturate | 34.1 | 39.2 | 17.1 | 24.5 | 22.2 | 40.3 |
16:1n-9 | 0.5 ± 0.3 | 0.9 ± 0.3 | 1.5 ± 0.8 | 3.4 ± 0.7* | 0.5 ± 0.2 | 1.2 ± 0.5 |
16:1n-7 | 0.7 ± 0.3 | 8.0 ± 0.8*** | 0.5 ± 0.2 | 4.1 ± 0.8** | 1.3 ± 0.5 | 7.0 ± 2.4* |
18:1n-9 | 35.9 ± 2.1 | 20.1 ± 0.2*** | 29.6 ± 3.4 | 22.1 ± 3.6 | 20.2 ± 3.7 | 19.3 ± 0.6 |
18:1n-7 | 3.3 ± 1.1 | 18.3 ± 2.3*** | 1.6 ± 0.2 | 13.8 ± 4.0* | 2.6 ± 1.0 | 20.5 ± 4.3** |
Total monoenoic | 40.4 | 47.3 | 33.2 | 43.4 | 24.6 | 48.0 |
18:2n-6 | 9.5 ± 1.2 | 3.4 ± 1.0* | 8.6 ± 2.5 | 6.4 ± 1.0 | 13.4 ± 1.7 | 3.7 ± 1.4* |
18:3n-6 | 10.6 ± 3.0 | 0.6 ± 0.3** | 31.8 ± 1.5 | 15.3 ± 2.4*** | 31.3 ± 3.8 | 1.3 ± 1.0*** |
20:3n-6 | 3.1 ± 1.4 | 1.5 ± 0.5 | 3.5 ± 0.9 | 3.5 ± 0.1 | 4.6 ± 0.2 | 1.1 ± 0.5* |
20:4n-6 | 0.7 ± 0.2 | 3.5 ± 1.0** | 0.3 ± 0.1 | 2.1 ± 0.8* | 0.5 ± 0.1 | 2.3 ± 0.8* |
Total n-6 | 23.9 | 9.3 | 44.2 | 27.3 | 49.5 | 8.4 |
18:3n-3 | nd | nd | nd | nd | nd | nd |
20:5n-3 | nd | 0.7 ± 0.3* | nd | nd | nd | nd |
22:5n-3 | 1.1 ± 0.9 | 1.6 ± 0.4 | 1.9 ± 0.3 | 1.9 ± 0.1 | 1.4 ± 0.9 | 1.7 ± 0.2 |
22:6n-3 | 0.5 ± 0.1 | 1.7 ± 0.6 | 3.6 ± 0.8 | 2.9 ± 0.3 | 2.0 ± 0.8 | 1.6 ± 0.1 |
Total n-3 | 1.6 | 4.2 | 5.5 | 4.8 | 3.4 | 3.3 |
Fatty acid composition was determined by GC analysis as described in materials and methods. Data, expressed as mole percent, are means of 3 independent experiments ± SD
* p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001 significant differences between promastigote and amastigote by t test